FDA PCAC reviews 7 peptides in July. Read →

PeptideXpo

AOD9604

Modified HGH fragment 176–191 (anti-obesity drug candidate)

≥ 99.0%CAS 221231-10-3GH-Axis Peptides

Overview

AOD9604 is a modified C-terminal fragment of human growth hormone (residues 176–191) developed as a lipolytic / anti-obesity research peptide. PeptideXpo supplies lyophilized AOD9604 at ≥99% HPLC purity with batch-specific COA.

Specifications

CAS
221231-10-3
Appearance
White lyophilized powder
Purity (HPLC)
≥ 99.0%
Common vial sizes
2 mg, 5 mg, 10 mg
MOQ
On request
Lead time
10–18 days
Storage
-20°C, protect from light

Documentation available on request

  • Certificate of Analysis (COA)
  • HPLC Chromatogram
  • Mass-spec spectrum
  • Stability data
  • SDS / MSDS
  • Sequence verification

Related peptides

Buyers who view AOD9604 also ask about:

HGH Fragment 176-191

C-terminal fragment of human growth hormone (176–191)

≥99.0%
CAS
66004-57-7
Vial
1 mg–15 mg
MOQ on requestGet quote →

Sermorelin

GHRH 1-29 fragment

≥99.0%
CAS
86168-78-7
Vial
2 mg–10 mg
MOQ on requestGet quote →

Ipamorelin

Ghrelin / GHSR pathway GH-release peptide

≥99.0%
CAS
170851-70-4
Vial
2 mg–10 mg
MOQ on requestGet quote →

See full catalog